ATLANTA (November 16, 2021) — Last week, Florence Healthcare hosted top clinical research executives from across the country for its Research Executive Summit in Atlanta. In its fourth year, the annual meeting brings together executives from Florence’s network of more than 10,000 research sites in 44 countries.
“Our Research Executive Summit enables us to better understand the challenges study sites and sponsors face and how we can help move the industry forward,” says Blake Adams, VP of Marketing for Florence. “We heard repeatedly at this meeting and at our larger Site Innovation Summit in October that remote technology is here to stay, but if it is not focused on improving site workflows, then it will adversely affect productivity, safety, and compliance.”
With technology permanently ingrained in the clinical trial research process as a result of the COVID-19 pandemic, Florence provided the platform to discuss technology and its impact in four key areas:
- Sites’ roles in decentralized clinical trials
- Building mutually beneficial solutions for sites and sponsors through technology
- Technology’s role in assisting clinical research employee onboarding and retention
- Benefits investigators realize by using technology in research
“Research sites told us loud and clear they want Florence to represent their technology interests,” says Ryan Jones, CEO of Florence. “Research sponsors now turn to us to learn how technology affects their study sites. By providing study sites with technology that simplifies their lives, we help sponsors speed up their study timelines and empower their sites.”
One key finding from summit discussions is that too many software systems slow down clinical research operations. Almost all sites reported that they are required to access 12-15 different platforms for each study — each requiring a separate login and lacking integration ability. In some cases, this triples their amount of administrative work.
“Having worked in academic and community sites for over 15 years, I understand firsthand the challenges of too many platforms,” noted Catherine Gregor, Chief Clinical Trial Officer for Florence. “If you want to truly drive efficient clinical trial timelines, then you need to create a holistic ecosystem of software – which starts with sponsors providing technology that enhances, rather than disrupts, site workflows.”
Florence is at the leading edge of site-friendly technology, supporting the decentralized process of clinical trials from study startup to data readout. By creating efficiencies for the entire research industry, Florence contributes to faster cures and better patient outcomes. For more information or to connect with us about upcoming events, please visit www.florencehc.com.
POWERED BY FLORENCE
Florence’s clinical trial software helps more than 10,000 research sites in 44 countries manage their documents, data, and workflows. The Florence platform also provides remote access so sponsors and CROs can collaborate with their sites around the world. Florence users now perform 3 million remote monitoring activities each month. To learn more, visit florencehc.com.